Literature DB >> 31786573

The Cellular Functions of Eosinophils: Collegium Internationale Allergologicum (CIA) Update 2020.

Hans-Uwe Simon1,2, Shida Yousefi3, Nina Germic3, Isabelle C Arnold4, Angela Haczku5, Alexander V Karaulov6, Dagmar Simon7, Helene F Rosenberg8.   

Abstract

Eosinophils and their secretory mediators play an important role in the pathogenesis of infectious and inflammatory disorders. Although eosinophils are largely evolutionally conserved, their physiologic functions are not well understood. Given the availability of new eosinophil-targeted depletion therapies, there has been a renewed interest in understanding eosinophil biology as these strategies may result in secondary disorders when applied over long periods of time. Recent data suggest that eosinophils are not only involved in immunological effector functions but also carry out tissue protective and immunoregulatory functions that actively contribute to the maintenance of homeostasis. Prolonged eosinophil depletion may therefore result in the development of secondary disorders. Here, we review recent literature pointing to important roles for eosinophils in promoting immune defense, antibody production, activation of adipose tissue, and tissue remodeling and fibrosis. We also reflect on patient data from clinical trials that feature anti-eosinophil therapeutics.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Asthma; Eosinophil cytolysis; Eosinophil degranulation; Eosinophil extracellular traps; Eosinophils; Hypereosinophilic syndromes; Inflammation; Interleukin-5; M2 macrophages; Major basic protein; Mast cells; Targeted therapy

Mesh:

Substances:

Year:  2019        PMID: 31786573      PMCID: PMC6940515          DOI: 10.1159/000504847

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  129 in total

1.  RhoH is a negative regulator of eosinophilopoiesis.

Authors:  Christina Stoeckle; Barbara Geering; Shida Yousefi; Saša Rožman; Nicola Andina; Charaf Benarafa; Hans-Uwe Simon
Journal:  Cell Death Differ       Date:  2016-10-14       Impact factor: 15.828

2.  CD8(+) T cells producing IL-3 and IL-5 in non-IgE-mediated eosinophilic diseases.

Authors:  C Stoeckle; H-U Simon
Journal:  Allergy       Date:  2013-11-11       Impact factor: 13.146

3.  Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus.

Authors:  Valdirene S Muniz; Juliana C Silva; Yasmim A V Braga; Rossana C N Melo; Shigeharu Ueki; Masahide Takeda; Akira Hebisawa; Koichiro Asano; Rodrigo T Figueiredo; Josiane S Neves
Journal:  J Allergy Clin Immunol       Date:  2017-09-21       Impact factor: 10.793

4.  Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.

Authors:  Yifu Qiu; Khoa D Nguyen; Justin I Odegaard; Xiaojin Cui; Xiaoyu Tian; Richard M Locksley; Richard D Palmiter; Ajay Chawla
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

Review 5.  New Anti-Eosinophil Drugs for Asthma and COPD: Targeting the Trait!

Authors:  Elisabeth H Bel; Anneke Ten Brinke
Journal:  Chest       Date:  2017-06-02       Impact factor: 9.410

6.  Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33.

Authors:  T Mahlakõiv; A-L Flamar; L K Johnston; S Moriyama; G G Putzel; P J Bryce; D Artis
Journal:  Sci Immunol       Date:  2019-05-03

7.  Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus.

Authors:  Simon Phipps; Chuan En Lam; Suresh Mahalingam; Matthew Newhouse; Ruben Ramirez; Helene F Rosenberg; Paul S Foster; Klaus I Matthaei
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

8.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.

Authors:  P D Ponath; S Qin; D J Ringler; I Clark-Lewis; J Wang; N Kassam; H Smith; X Shi; J A Gonzalo; W Newman; J C Gutierrez-Ramos; C R Mackay
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

9.  Homologous recombination into the eosinophil peroxidase locus generates a strain of mice expressing Cre recombinase exclusively in eosinophils.

Authors:  Alfred D Doyle; Elizabeth A Jacobsen; Sergei I Ochkur; Lian Willetts; Kelly Shim; Joseph Neely; Jake Kloeber; Will E Lesuer; Ralph S Pero; Paige Lacy; Redwan Moqbel; Nancy A Lee; James J Lee
Journal:  J Leukoc Biol       Date:  2013-04-29       Impact factor: 4.962

10.  Susceptibility to L. sigmodontis infection is highest in animals lacking IL-4R/IL-5 compared to single knockouts of IL-4R, IL-5 or eosinophils.

Authors:  Stefan J Frohberger; Jesuthas Ajendra; Jayagopi Surendar; Wiebke Stamminger; Alexandra Ehrens; Benedikt C Buerfent; Katrin Gentil; Achim Hoerauf; Marc P Hübner
Journal:  Parasit Vectors       Date:  2019-05-20       Impact factor: 4.047

View more
  20 in total

Review 1.  Controversies in Allergy: The Potential Role of Biologics as First-Line Therapy in Eosinophilic Disorders.

Authors:  Evan S Dellon; Dagmar Simon; Michael E Wechsler
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-12

2.  ATG5 promotes eosinopoiesis but inhibits eosinophil effector functions.

Authors:  Nina Germic; Aref Hosseini; Darko Stojkov; Kevin Oberson; Meike Claus; Charaf Benarafa; Sara Calzavarini; Anne Angelillo-Scherrer; Isabelle C Arnold; Anne Müller; Carsten Riether; Shida Yousefi; Hans-Uwe Simon
Journal:  Blood       Date:  2021-05-27       Impact factor: 22.113

Review 3.  Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids.

Authors:  Eva Knuplez; Eva Maria Sturm; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

Review 4.  Intestinal eosinophils, homeostasis and response to bacterial intrusion.

Authors:  Alessandra Gurtner; Ignacio Gonzalez-Perez; Isabelle C Arnold
Journal:  Semin Immunopathol       Date:  2021-04-30       Impact factor: 9.623

5.  Benralizumab for severe DRESS in two COVID-19 patients.

Authors:  Peter Schmid-Grendelmeier; Peter Steiger; Mirjam C Naegeli; Isabel Kolm; Claudia Cécile Valérie Lang; Emanual Maverakis; Marie-Charlotte Brüggen
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10-08

Review 6.  The Known Unknowns of the Immune Response to Coccidioides.

Authors:  Rebecca A Ward; George R Thompson; Alexandra-Chloé Villani; Bo Li; Michael K Mansour; Marcel Wuethrich; Jenny M Tam; Bruce S Klein; Jatin M Vyas
Journal:  J Fungi (Basel)       Date:  2021-05-11

Review 7.  Eosinophils in skin diseases.

Authors:  Susanne Radonjic-Hoesli; Marie-Charlotte Brüggen; Laurence Feldmeyer; Hans-Uwe Simon; Dagmar Simon
Journal:  Semin Immunopathol       Date:  2021-06-07       Impact factor: 9.623

Review 8.  An Eclectic Cast of Cellular Actors Orchestrates Innate Immune Responses in the Mechanisms Driving Obesity and Metabolic Perturbation.

Authors:  Lakshmi Arivazhagan; Henry H Ruiz; Robin A Wilson; Michaele B Manigrasso; Paul F Gugger; Edward A Fisher; Kathryn J Moore; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

Review 9.  Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies.

Authors:  Helene F Rosenberg; Paul S Foster
Journal:  Semin Immunopathol       Date:  2021-03-16       Impact factor: 9.623

Review 10.  Eosinophils and Bacteria, the Beginning of a Story.

Authors:  Edna Ondari; Esther Calvino-Sanles; Nicholas J First; Monica C Gestal
Journal:  Int J Mol Sci       Date:  2021-07-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.